Page last updated: 2024-08-21

methoxyhydroxyphenylglycol and Cognitive Dysfunction

methoxyhydroxyphenylglycol has been researched along with Cognitive Dysfunction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jacobs, HIL; Riphagen, JM; van Egroo, M1
Aerts, T; De Deyn, PP; Fransen, E; Gerritsen, MJ; Spikman, JM; Van Dam, D; van der Zee, S; van Laar, T; Vermeiren, Y1

Other Studies

2 other study(ies) available for methoxyhydroxyphenylglycol and Cognitive Dysfunction

ArticleYear
Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline.
    Journal of Alzheimer's disease : JAD, 2021, Volume: 80, Issue:2

    Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Humans; Learning; Locus Coeruleus; Male; Memory Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Norepinephrine; Predictive Value of Tests; tau Proteins

2021
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
    Journal of Parkinson's disease, 2018, Volume: 8, Issue:1

    Topics: Aged; Biogenic Monoamines; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Diagnosis, Differential; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lewy Body Disease; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Retrospective Studies

2018